CEO of Biomarin Pharmaceutical Inc (30-Year Financial, Insider Trades) Jean Jacques Bienaime (insider trades) sold 8,000 shares of BMRN on 12/27/2019 at an average price of $86.26 a share. The total sale was $690,080.
Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions. Biomarin Pharmaceutical Inc has a market cap of $15.19 billion; its shares were traded at around $84.59 with and P/S ratio of 9.52. GuruFocus has detected 2 severe warning signs with Biomarin Pharmaceutical Inc. .
CEO Recent Trades:
- CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 12/27/2019 at the average price of $86.26. The price of the stock has decreased by 1.94% since.
Directors and Officers Recent Trades:
- Director V Bryan Lawlis sold 3,750 shares of BMRN stock on 12/17/2019 at the average price of $83.36. The price of the stock has increased by 1.48% since.
For the complete insider trading history of BMRN, click here
.